Search research articles
Contact Us
Filters
Showing results (311-320 of 358) with videos related to
Page
of 36
Sort By:
Journal of Personalized Medicine
|
November 24, 2022
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows
Marco Montella, Giovanni Ciani, Vincenza Granata, et al.
Molecular Metabolism
|
August 9, 2022
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
Ugo Chianese, Chiara Papulino, Eugenia Passaro, et al.
Journal of Medicinal Chemistry
|
December 23, 2015
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer Cells
Sergio Valente, Paolo Mellini, Francesco Spallotta, et al.
Cancer Research
|
February 26, 2014
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392
Floriana De Bellis, Vincenzo Carafa, Mariarosaria Conte, et al.
Clinical Epigenetics
|
September 28, 2022
Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
Clemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Clinical Epigenetics
|
May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
Clemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Nature Chemical Biology
|
October 26, 2023
Targeting ROS production through inhibition of NADPH oxidases
Joana Reis, Christoph Gorgulla, Marta Massari, et al.
Cell Death & Disease
|
October 6, 2025
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia
Ada Pesapane, Lucia Capasso, Maria Rosaria Del Sorbo, et al.
Journal of Hematology & Oncology
|
February 22, 2026
UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignancies
Carmela Dell'Aversana, G Sgueglia, C Massaro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 3, 2008
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment
Claudia Colussi, Chiara Mozzetta, Aymone Gurtner, et al.
Page
of 36
Search research articles
Search
Showing results (311-320 of 358) with videos related to
Sort By:
Page
of 36
Journal of Personalized Medicine
|
November 24, 2022
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows
Marco Montella, Giovanni Ciani, Vincenza Granata, et al.
Molecular Metabolism
|
August 9, 2022
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
Ugo Chianese, Chiara Papulino, Eugenia Passaro, et al.
Journal of Medicinal Chemistry
|
December 23, 2015
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer Cells
Sergio Valente, Paolo Mellini, Francesco Spallotta, et al.
Cancer Research
|
February 26, 2014
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392
Floriana De Bellis, Vincenzo Carafa, Mariarosaria Conte, et al.
Clinical Epigenetics
|
September 28, 2022
Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
Clemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Clinical Epigenetics
|
May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
Clemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Nature Chemical Biology
|
October 26, 2023
Targeting ROS production through inhibition of NADPH oxidases
Joana Reis, Christoph Gorgulla, Marta Massari, et al.
Cell Death & Disease
|
October 6, 2025
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia
Ada Pesapane, Lucia Capasso, Maria Rosaria Del Sorbo, et al.
Journal of Hematology & Oncology
|
February 22, 2026
UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignancies
Carmela Dell'Aversana, G Sgueglia, C Massaro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 3, 2008
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment
Claudia Colussi, Chiara Mozzetta, Aymone Gurtner, et al.
Page
of 36